Amping up T cells to target cancerhttps://www.technologyreview.com/2026/08/25/1140949/amping-up-t-cells-to-target-cancer
Vaccines that turn the body’s immune system against tumors have shown promise in clinical trials, and a handful have been FDA approved for certain cancers. In many patients, however, these vaccines don’t stimulate enough of a response, and the approach some researchers have taken to strengthening it—delivering the vaccine along with immune-stimulating molecules called cytokines—can…
